This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 4.0.1. For a full list of available versions, see the Directory of published versions
This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile DetectedIssue.
Severity: High - Risk of internal bleeding
Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.
Mitigation: Jan 5, 2014 by Dr. Adam Careful:
Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.